Andrew Handorf

Andrew Handorf is an accomplished professional in the biopharmaceutical and commercial operations sectors, currently serving as Director of Commercial Operations at Bionova Scientific since April 2024. Prior to this role, Andrew held the position of Director of Proposals at Scorpius BioManufacturing, Inc. from March 2023 to April 2024, and spent six years at Catalent Pharma Solutions in various roles, culminating as Associate Director of Commercial Operations, Evaluations & Proposals. During tenure at Catalent, Andrew excelled in proposal customization, cross-site communication, and new product evaluation processes. Andrew's academic background includes a Ph.D. in Biomedical Engineering from the University of Wisconsin-Madison, where research focused on gene therapy for type 1 diabetes mellitus, along with a BS in Biology/Chemistry from Edgewood College.